Estradiol intradermal injection - RenovoAlternative Names: Zesteem
Latest Information Update: 20 Jun 2011
At a glance
- Originator Renovo
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Wounds
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 10 May 2006 Phase-II clinical trials in Wounds in United Kingdom (Intradermal)